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We investigated the effects of zonisamide, a new antiepileptic drug, on voltage-dependent T-type c&lcium current 
(I¢,) in cultured neuroblastoma cells of human origin (NB-I). Zonisamide reduced T-type Ic, in a concentration- 
dependent manner without evoking any change in its inactivation kinetics or voltage dependence of action. The 
mean percent reduction was 38.3 + 5.8% at 50 p.M. Further, zonisamide shifted the inactivation curve approxi- 
mately 20 mV negative compared to the control. These resting blocking actions uggest hat zonisamide shifts the 
channel population toward the inactivation state, allowing fewer channels to open during membrane depolariza- 
tion. The blockade of T-type calcium channels by zonisamide could suppress an important component of inward 
current hat underlies epileptiform cellular bursting, thereby inhibiting the spread of seizure activity. 
Key words: zonisamide; absence seizure; calcium channel currents; whole-cell clamp recording; human neuroblas- 
toma cell line. 
INTRODUCTION 
Zonisamide (ZNS; 1,2-benzisoxazole-3-methane- 
sulfonamide; AD-810; CI-912), a derivative of 
3-(sulfamoylmethyl)-l,2-benzisoxazole, is a mem- 
ber of novel class of anticonvulsants. ZNS has 
been proven effective in the treatment of both 
partial and generalized seizures ~. Studies of its 
cellular mechanisms of action, especially its 
effects on ionic channels, have shown that ZNS 
blocks the sustained firing of action potentials 
recorded intracellularly in cultured spinal cord 
neurons 2, and that it affects the steady-state 
inactivation of sodium channels 3. Recently, Su- 
zuki et al 4 reported that ZNS blocked T-type 
calcium channels in cultured rat cerebral cortical 
neurons. We have also reported that ZNS reduces 
T-type Ic~ in human neuroblastoma cells 5. 
Unfortunately, the mechanisms whereby ZNS 
exerts its action on calcium channels are incom- 
pletely understood. In this study, we examined 
the effects of ZNS on T-type Ic~ in the human 
neuroblastoma cell line NB-I. We used a whole- 
cell voltage-clamp technique, recording in regard 
to two points: (1) concentration dependent 
blockade by ZNS of T-type Ica, and (2) the effects 
of ZNS on T-type calcium channel inactivation. 
METHODS 
Cell culture 
The human neuroblastoma cell line NB-I estab- 
lished by Miyake et al was used 6. Cells were 
cultured in RPMI 1640 medium, pH 7.4, supple- 
mented with 10% fetal calf serum at a tempera- 
ture of 37°C. NB-I cells were replaced on a small 
glass-covered culture dish and incubated for two 
to seven days before use. 
Recording conditions 
Whole cell recording by the patch-clamp tech- 
nique, was used to record T-type Ica in the 
neuroblastoma cell membrane under the voltage- 
clamp conditions 7. The cut-off frequency of the 
recording system was 700Hz. The recording 
chamber (bath volume 0.2ml) in which NB-I 
cells were fixed was perfused via a gravity-fed 
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perfusion system at a rate of 2 ml/min. T-type Ica 
was evoked by applying step-depolarization f 
400ms duration from -100mV to +80mV in 
10-mV steps from a holding potential of -80 mV. 
Experiments were carried out at room tempera- 
ture (22-25°C). 
The normal external medium used contained, 
in mM:NaCI 36.7, BaC12 51.2, MgCI2 1.18, 
glucose 11.8, HEPES-Na 10.0, tetraethylam- 
monium chloride (TEA) 23.6, and tetrodotoxin 
(TTX) 3 × 10 -3, at pH 7.4. The patch pipette was 
filled with a solution containing, in mM :Cs-ASP 
106.2, CsCI 23.6, MgCI2 4.95, ATP-Na2 4.95, 
EGTA 9.9, HEPES-Na 4.95, and CaCI2 1.26, at 
pH 7.0. The resistance of the patch pipette in the 
normal external solution was between 3 and 
5 MfL Ba 2÷ was used in the normal external 
solution since it is more permeable to Ca 2÷ 
channels and the amplitude is easier to analyse 
than with Ca 2÷ 8. 
ZNS was dissolved in dimethyl sulfoxide 
(DMSO) and this solution was added at various 
ZNS concentrations, to the normal external 
solution. The final concentration of DMSO was 
0.5%, at which concentration DMSO inhibited 
T-type Ic~ by 4.3 ± 4.3% (n = 5). To differentiate 
the effects of DMSO and ZNS, the concentration 
of DMSO was maintained at 0.5% in all test 
solutions. The effect of 0.5% DMSO was taken 
into account when we calculated the percent 
inhibition in the experiment. 
Approximately 50% of ZNS is bound to plasma 
proteins. Free plasma levels of ZNS are equal to 
those in cerebrospinal fluid (CSF). The physio- 
logically relevant concentrations are presumed to 
be closer to the free brain concentration, which, 
in turn, is thought to be equivalent to CSF levels 9. 
The therapeutic level of ZNS is 50tzM 
(21.2/xg/ml) 1. In this study, we used ZNS at a 
concentration f 50/zM. 
Data recording and analysis 
The membrane currents recorded in the whole 
cell clamp mode, with a pre-amplifier (CEZ 2300; 
Nihon Kohden, Tokyo, Japan) were fed to a 
12-bit analog-digital converter in a personal 
computer (IBM, USA). The computer was also 
used to control the membrane potential. Data 
were plotted as the current-voltage r lationship 
(I-V curve) and the amplitude was analysed 
before and 5 minutes after the application of 
ZNS, and after ZNS had been washed out. Data 
were analysed with the PCLAMP version 5.51 
(Axon Instruments, Inc., USA), and numerical 
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values were expressed as means ± SEM. Wilcoxon 
analysis was used in the statistical analysis. 
RESULTS 
Characterization of T-type Ica 
T-type Ic, was activated by depolarizing poten- 
tials exceeding -50 mV and reached a maximum 
at 0 mV. T-type I¢, was rapidly inactivated during 
depolarizing test potential and its time constant at 
-10 mV test potential was 22.5 + 5.7 ms (Fig. 1). 
Ni 2÷ at 100/zM inhibited T-type Ic. by 82.6+ 
15.3% (n = 6). On the other hand, Cd 2÷ had little 
effect on T-type Ic, (11.4+3.2% at 100p.M, 
n =7). La 3÷ at 10~M inhibited T-type Ic, by 
24.3 + 5.5% (n = 4). Nifedipine 1° at 10 ~M inhib- 
ited T-type Ic, by 20.6+0.6% (n =3). to- 
CgTX ~ 5 p.M inhibited T-type Ic~ by 12.9 ± 7.6% 
(n =5). At a concentration of 10/~M, Bay K 
864412 did not enhance the T-type I¢~ (n = 5). 
T-type Ica was detected in 72.8% of NB-I cells 
examined (n = 87). 
Effect of ZNS on T-type Ica 
At a concentration of 100p.M, ZNS inhibited 
T-type Ic~ by 83.8%, but its inactivation kinetics 
was unchanged and the voltage dependence of 
current activation was not altered (Fig. 1). Figure 
2 shows the results of the concentration-response 
experiments. ZNS reduction of T-type Ica was 
concentration-dependent. The percent inhibition 
exerted by 50/xM ZNS was 38.3 + 5.8% (n = 5). 
Voltage dependence of T-type calcium channel 
inactivation 
Voltage dependence T-type calcium channel 
inactivation was tested with another series of 
experiments. Ica was evoked by applying 350-ms 
prepulse from a holding potential of -100 mV, 
between -120 mV and +40 mV, in 10-mV steps, 
followed by a test potential to 0 mV. Relative 
peak amplitudes of the inward currents were 
plotted against the voltage level during the 
prepulse. T-type calcium channel inactivation was 
strongly inhibited between -90 mV and -20 mV, 
and was completely inactivated at +10mV 
prepulse. The data points for T-type Ic, were 
fitted with a continuous mooth curve derived 
from the Boltzmann equation with a mid-point of 
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Fig. 1: Effects of ZNS on T-type Ica and on the current-voltage relationships of Ica. Typical inward currents evoked by applying 
step-depolarization-from holding potentials of -80 mV to the test potentials indicated. The current was measured before and 5 
minutes after the application of ZNS and 5 minutes after the wash out of ZNS. ZNS (100/~M) inhibited T-type Ica by 83.8%, but 
inactivation kinetics was unchanged and the voltage-dependence of current activation was not altered. 
-50.4 + 1.5 mV and slope parameter of 14.8 + 
1.1 mV (n =4; Fig. 3). T-type calcium channel 
inactivation exerted by ZNS was strongly 
inhibited between -100 and -40mV; and 
completely inactivated at 0mV prepulse. The 
data points for T-type calcium channel 
inactivation by ZNS were also fitted with a 
continuous smooth curve derived from the 
Boltzmann equation, with a mid-point of 
-69.8 ± 2.1 mV and a slope parameter of 12.5 + 
0.8 mV (n = 4; Fig. 3). The membrane potential 
at half inactivation for ZNS was about 20 mV 
more negative than that for control (P<0.01, 
Wilcoxon analysis). 
DISCUSSION 
ZNS, one of a novel class of of benzisoxazole 
anticonvulsants, has been proven effective in the 
treatment of simple/complex partial seizures and 
secondarily generalized tonic-clonic seizures, 
generalized tonic-clonic seizures, tonic seizures, 
atypical absence seizures and a combination of 
these ~. The mechanism of action of ZNS, in 
particular, its effect on ionic channels, is incompl- 
etely understood. Schauf et al 3 reported that 
zonisamide nhanced slow medium inactivation 
in Myxicola. Suzuki et al 4 reported that zonisa- 
mide blocked T-type calcium channel in cultured 
neurons of rat cerebral cortex. Recently, we also 
reported that ZNS blocked T- and L-type Ica in 
cultured human neuroblastoma cells 5. 
Recent reports have demonstrated that there 
are at least three types of Ca 2÷ channels in 
neuronal cells a'1°'~3. Calcium channels play im- 
portant roles in the regulation of many cellular 
functions, including excitability, transmitter e- 
lease, contraction, metabolism, and gene 
expressions 14. The T-type calcium channels may 
be involved in a near-threshold membrane 
potential. For example, they may speed up the 
rate of depolarization to the threshold potential 
after neuronal hyperpolarization. Suzuki et al t5 
reported that T-type Ca 2÷ channels mediated the 
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Fig. 2: Plots of ZNS concentration (logarithmic scale) vs. 
percentage inhibition of T-type Ica (error bars show 
mean + SEM of the number of cells per point). The percent 
inhibition was calculated for the transient inward current 
(measured at the peak) elicited by a 0 mV command. Since 
0.5% DMSO in the bath solution reduced T-type Ica by 4.3%, 
the percent inhibition in the plot represents nominal 
inhibition minus 4.3%. The curve for T-type Ica, which was 
fitted to the data by eye, was constructed from the standard 
concentration-response quation. This equation assumed 
one-to-one stoichiometry between ZNS concentration and 
effect on T-type Ica. 
suximide and valproic acid are antiepileptics, it is 
thought that the T-type calcium channel is 
involved in the generation of absence seizures. 
This study has shown that ZNS suppresses T-type 
Ica without altering its inactivation kinetics or 
voltage dependence. Two different aspects of 
T-type calcium channel blockade were 
distinguished. The first aspect was a resting 
blockade in which ZNS blocked T-type Ic, in a 
concentration-dependent manner. At a close 
equivalent o the therapeutic level, ZNS (50/ZM) 
inhibited T-type Ica by 38.3-4-5.8%, a result 
similar to the findings of Suzuki et al 4. The second 
aspect was that ZNS enhanced steady-state 
inactivation. ZNS (50/~M) shifted the T-type 
channel inactivation curve approximately 20 mV 
to the negative compared with the control. 
In conclusion, ZNS inhibited T-type Ica in a 
concentration-dependent manner, and it en- 
hanced steady-state inactivation. The blockade of 
T-type calcium channels by ZNS could suppress 
an important component of the inward current 
that underlies epileptiform cellular bursting, 
thereby inhibiting the spread of seizure activity. 
transition between tonic and phasic firing in 
thalamic neurons. The blockade of T-type Ica 
may play a role in the depressant action of such 
anitiepileptic drugs as phenytoin, valproic acid, 
and ethosuximide on repetitive neuronal firing, 
and may thereby contribute to their efficacy in 
suppressing epileptic discharges '6-ts. Since etho- 
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Fig. 3: Voltage-dependence of T-type calcium channel 
inactivation. The test pulses for the activation of T-type 
calcium currents (350 ms, 0 mV) were preceded by 350-ms 
conditioning pulses to various membrane potentials (inset). 
Current amplitudes, normalized to the value obtained with a 
test pulse of 0 mv, were plotted as a function of conditioning 
potential. The application of 50/~M ZNS produced a 
hyperpolarizing shift of about 20 mV in the T-type calcium 
channel inactivation curve. 
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